Enhanced IκB kinase activity is responsible for the augmented activity of NF-κB in human head and neck carcinoma cells

Cancer Letters

Volumn 171, Issue 2, 2001, Pages 165-172

  Tamatani, Tetsuya ^a   Azuma, Masayuki ^a   Aota, Keiko ^a   Yamashita, Tsuyoshi ^a   Bando, Takashi ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Head and neck carcinoma; I B ; I B kinase; NF B

Indexed keywords

I KAPPA B; I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN INDUCING KINASE; MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEIN P50; SYNAPTOTAGMIN; UNCLASSIFIED DRUG; CHUK PROTEIN, HUMAN; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; ISOENZYME; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR RELA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL CULTURE; ENZYMOLOGY; GENETICS; HEAD AND NECK TUMOR; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; I-KAPPA B KINASE; ISOENZYMES; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA; TUMOR CELLS, CULTURED;

EID: 0035840790     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00611-5     Document Type: Article

References (35)

1. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
2. NF-κB: Ten years after
3. Suppression of TNF-α-induced apoptosis by NF-κB
4. Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo
5. Down-regulation of nuclear factor κB is required for p53-dependent apoptosis in X-ray-irradiated mouse lymphoma cells and thymocytes
6. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells
7. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-κB activation
8. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome
9. The host environment promotes the constitutive activation of nuclear factor-κB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma
10. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli
11. IκBα overexpression in human breast carcinoma MCF7 cells inhibit nuclear factor-κB activation but not tumor necrosis factor-α-induced apoptosis
12. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells
13. NAK is an IκBα kinase-activating kinase
14. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NF-κB p65 protein expression
15. Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells
16. Constitutive nuclear translocation of NF-κB in B cells in the absence of IκB degradation
17. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation
18. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
19. Intermediate-sized filaments and specific markers in a human salivary gland adenocarcinoma cell lines and its nude mouse tumors
20. An adenoid-squamous-carcinoma-forming cell line established from an oral keratinizing squamous-cell carcinoma expressing carcinoembryonic antigen
21. Expression of vasoactive intestinal polypeptide and amylase in a human parotid gland adenocarcinoma cell line in culture
22. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous cancer cell lines
23. Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro
24. Direct transport of newly synthesized HLA-DR from the trans-golgi networks to major histocompatibility complex classII containing compartments (MIICS) demonstrated using a novel tyrosine-sulfated chimera
25. Immunosuppressant FK506 activates NF-κB through the proteasome-mediated degradation of IκBα
26. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and cIAP1 and c-IAP2 to suppress caspase-8 activation
27. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-κB signaling
28. Constitutive activation of transcription factors NF-κB, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines
29. Inhibition of transcription factor nuclear factor κB by a mutant inhibitor κBα attenuates resistance of human head and neck squamous cell carcinoma to TNF-α caspase-mediated cell death
30. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-κB signal pathways
31. Cisplatin and radiation sensitivity in human head and neck squamous carcinoma are independently modulated by glutathione and transcription factor NF-kappaB
32. Disruption of IκBα regulation by antisense RNA expression leads to malignant transformation
33. Tumor necrosis-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathway
34. NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase
35. 5-Fluorouracil induces apoptosis through the suppression of NF-κB activity in human salivary gland cancer cells